1. Home
  2. UGRO vs TSBX Comparison

UGRO vs TSBX Comparison

Compare UGRO & TSBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UGRO
  • TSBX
  • Stock Information
  • Founded
  • UGRO 2014
  • TSBX 2015
  • Country
  • UGRO United States
  • TSBX United States
  • Employees
  • UGRO N/A
  • TSBX N/A
  • Industry
  • UGRO Industrial Specialties
  • TSBX
  • Sector
  • UGRO Consumer Discretionary
  • TSBX
  • Exchange
  • UGRO Nasdaq
  • TSBX Nasdaq
  • Market Cap
  • UGRO 18.0M
  • TSBX 11.4M
  • IPO Year
  • UGRO N/A
  • TSBX 2023
  • Fundamental
  • Price
  • UGRO $1.07
  • TSBX $0.48
  • Analyst Decision
  • UGRO Strong Buy
  • TSBX Buy
  • Analyst Count
  • UGRO 2
  • TSBX 3
  • Target Price
  • UGRO $5.63
  • TSBX $4.75
  • AVG Volume (30 Days)
  • UGRO 55.3K
  • TSBX 90.5K
  • Earning Date
  • UGRO 12-27-2024
  • TSBX 11-12-2024
  • Dividend Yield
  • UGRO N/A
  • TSBX N/A
  • EPS Growth
  • UGRO N/A
  • TSBX N/A
  • EPS
  • UGRO N/A
  • TSBX N/A
  • Revenue
  • UGRO $70,320,066.00
  • TSBX N/A
  • Revenue This Year
  • UGRO $14.76
  • TSBX N/A
  • Revenue Next Year
  • UGRO $21.29
  • TSBX N/A
  • P/E Ratio
  • UGRO N/A
  • TSBX N/A
  • Revenue Growth
  • UGRO 12.08
  • TSBX N/A
  • 52 Week Low
  • UGRO $0.93
  • TSBX $0.40
  • 52 Week High
  • UGRO $2.84
  • TSBX $5.75
  • Technical
  • Relative Strength Index (RSI)
  • UGRO 33.37
  • TSBX 39.58
  • Support Level
  • UGRO $1.17
  • TSBX $0.48
  • Resistance Level
  • UGRO $1.19
  • TSBX $0.51
  • Average True Range (ATR)
  • UGRO 0.11
  • TSBX 0.05
  • MACD
  • UGRO -0.02
  • TSBX -0.00
  • Stochastic Oscillator
  • UGRO 24.78
  • TSBX 22.22

About UGRO urban-gro Inc.

Urban-gro Inc is an integrated professional services and construction design-build firm. Its business focuses predominantly on providing fee-based knowledge-based services as well as the value-added reselling of equipment. The company offers value-added architectural, engineering, systems procurement and integration, and construction design-build solutions to customers operating in the controlled environment agriculture (CEA) and industrial and other commercial (Commercial) sectors. It derives revenue predominately from the sale of equipment systems, services, construction design-build, and other various immaterial contracts with customers.

About TSBX Turnstone Biologics Corp.

Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.

Share on Social Networks: